Published in Medical Letter on the CDC and FDA, December 26th, 2004
According to a study from the United States, "The U.S. Food and Drug Administration (FDA) has approved several applications for the marketing of neurologic devices. Nineteen high-risk Class III medical devices were approved for the central and peripheral nervous system for marketing between 1994 and 2003, and almost half (n=8) include indications for use in children as well as adults."
"On July 24, 2003, the FDA Center for Devices and Radiologic Health released for public comment a draft guidance...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.